Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.40%44 Gross Margin % is 49.97% as of Dec. 2025, which is 5% below its 10-year median of 52.51. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 732 Biotechnology companies, Synbio Tech ranks worse than 57.24% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Synbio Tech's Gross Profit for the
three
months ended in Dec. 2025 was NT$142 Mil. Synbio Tech's Revenue for the
three
months ended in Dec. 2025 was NT$285 Mil. Therefore, Synbio Tech's Gross Margin % for the quarter that ended in Dec. 2025 was 49.97%.
The historical rank and industry rank for Synbio Tech's Gross Margin % or its related term are showing as below:
ROCO:1295'
s Gross Margin % Range Over the Past 10 Years
Min: 48.87 Med: 52.51 Max: 54.66
Current: 53.45
During the past 6 years, the highestGross Margin % of Synbio Tech was 54.66%. The lowest was 48.87%. And the median was 52.51%.
ROCO:1295's Gross Margin % is ranked worse than 57.24% of 732
companies
in the Biotechnology industry
Industry Median: 60.905
vs ROCO:1295: 53.45
Synbio Tech had a gross margin of 49.97% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Synbio Tech was 0.70% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Synbio Tech had a gross margin of 49.97% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Synbio Tech Gross Margin % Related Terms
Synbio Tech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Synbio Tech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Synbio Tech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Synbio Tech (ROCO:1295) has a Gross Margin % of 49.97% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Synbio Tech and its competitors. This is near median its historical median of 52.51. Over the past decade, Synbio Tech's Gross Margin % has ranged from 48.87 to 54.66. According to the industry distribution chart, Synbio Tech ranks #419 out of 732 companies in the Biotechnology industry, placing it in the top 57.2%.
Is Synbio Tech's Gross Margin % too high?
Synbio Tech's current Gross Margin % of 49.97% is near median its 10-year median of 52.51. Over the past 10 years, this metric has ranged from a low of 48.87 to a high of 54.66. The Biotechnology industry median Gross Margin % is 60.91. Synbio Tech's value of 49.97% is 18% below this industry median. Based on the distribution chart, Synbio Tech ranks #419 out of 732 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #419 out of 732 companies for Gross Margin %. This places Synbio Tech in the lower half of its industry. The industry median Gross Margin % is 60.91. Synbio Tech's value of 49.97% is 18% below this benchmark. Historically, Synbio Tech's own Gross Margin % has ranged from 48.87 to 54.66 over the past decade. While the company's 10-year median is 52.51 vs. the industry median of 60.91, Synbio Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synbio Tech's current Gross Margin % of 49.97% is 18% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Synbio Tech and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synbio Tech's current Gross Margin % is 49.97%, which is near median its own 10-year median of 52.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Gross Margin % of 49.97%. The current Gross Margin % is 49.97%, which is near median its 10-year median of 52.51 and 18% below the Biotechnology industry median of 60.91. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Gross Margin % is 49.97% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
